TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Business

    Investing Experts

    Seeking Alpha’s deep dive stock analysis and topical takes on the market with top analysts and industry experts. Hosted by Rena Sherbill.

    Transcripts: seekingalpha.com/author/investing-experts-podcast

    Advertise

    Copyright: © Copyright Seeking Alpha

    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    Don't rely on past performance Feb 26, 2024
    Show notes

    Rob Isbitts talks portfolio strategies, why he combines offense and defense and why he's not a fan of the 60-40 approach (1:10). International markets and ETFs (13:47). Too much focus on stock picks and past performance (19:40).
    Show Notes:
    My Top 3 YARP Stocks Right Now (Yield At A Reasonable Price)
    Embracing The Mania And Yield At A Reasonable Price
    IZRL: Long-Term Comeback Candidate, Strong Buy
    Seeking Alpha's Quant Performance
    The Key To Investing Success Is Being Wrong A Lot
    Episode transcripts
    For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions


    If you can predict cash flow you can predict stock price - Austin Hankwitz Feb 22, 2024
    Show notes

    Why Austin Hankwitz is focused on profitability and cash flow (1:55). Russell 2000 is weirdly undervalued (5:25). Breaking down covered call ETFs SPYI, JEPI and XYLD performance (8:30). Why he's so bullish on Salesforce (22:30).
    Show Notes:
    'Stay Hungry, Stay Foolish' Small Cap Strategies With Courage & Conviction Investing
    JEPI: Much To Be Desired In 2024
    SPYI: Outperforming Both JEPI And XYLD In 2023
    $2 Million Dividend Growth Portfolio, Major Tech Earnings, Broadcom & SPYI With Austin Hankwitz
    Episode transcripts
    For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
    Rich Habits Podcast
    Austin Hankwitz Twitter


    Letting winners run - Steven Cress on Alpha Picks' outperformance Feb 16, 2024
    Show notes

    Seeking Alpha's quant guru Steven Cress talks about why Alpha Picks is up 100% and lets winners run (1:00), how to trade a huge winner like Super Micro (11:05) and how an alpha portfolio can bring income as well (16:00).
    Show Notes:
    Quant Rating Spies More Top Stocks As Market Breadth Widens With Steven Cress
    Dividend Picks For Growth And Safety With Steven Cress
    Alpha Picks
    Episode transcripts
    For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions


    Should we trust economic data? With Danielle DiMartino Booth Feb 14, 2024
    Show notes Danielle DiMartino Booth on why Fed Chairman Jay Powell wants to keep rates high (1:15). Should we trust the CPI and other economic data coming out? (3:30) Stubbornness of the yield curve inversion (14:20) Real earnings running negative more important than headline retail sales. (17:15)
    Show Notes:
    Wall Street Breakfast: Trust The Data
    January CPI Comes In Hot
    US2Y and US10Y jump to 2024 highs after stronger CPI print
    Episode transcripts
    For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
    Danielle DiMartino Booth on Twitter
    QI Research

    Super Bowl streaming, Disney deep dive and why numbers don't lie Feb 13, 2024
    Show notes

    Dan Rayburn talks overall positive Super Bowl streaming numbers (1:00). Contextualizing Paramount's bad press (3:15). Disney's recent earnings, ESPN and sports joint venture (10:45). Integration between betting and streaming sports. (45:20).
    Show Notes:
    Exciting Time For Streaming Sports, But Broadcast + Pay TV Aren't DeadParamount gains as Super Bowl audience surges to 126.6M viewers
    The Walt Disney Company Q1 2024 Earnings Call Transcript
    Disney/Fox/Warner sports streamer shakes up market, though big questions remain
    Episode transcripts
    For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions


    J Mintzmyer on Red Sea disruptions and 2 key shipping segments Feb 06, 2024
    Show notes

    J Mintzmyer explains the ins and outs of the shipping sector (3:00). Why the Suez Canal and Red Sea matter so much to the industry (5:50). Investment opportunities in tankers and containerships (14:20). Why ZIM is such a volatile stock (24:55) and why J doesn't love the shipping ETF BOAT (26:15). This is an abridged conversation from Seeking Alpha's recent video webinar.
    Subscribe to J's Value Investor's Edge
    Show Notes:
    J Mintzmyer's 2 Favorite Tankers
    J Mintzmyer Unpacks Cyclical And Fickle Shipping Sector
    Episode transcripts
    For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions


    5 cannabis stocks and how retail investors should navigate the industry Jan 31, 2024
    Show notes

    Nick Gastevich, aka CannaVestments, helps retail investors navigate the cannabis industry; companies that protect shareholders (0:55). 5 stocks: Green Thumb, Trulieve, Curaleaf, Glass House and Jushi - what's working, what's not (5:00). This is an abridged conversation from Seeking Alpha's recent Cannabis Investing Podcast.
    Show Notes:
    Senate Democrats urge DEA to end marijuana restrictions completely
    Cannabis stocks rally as support builds for DEA rescheduling
    HHS document shows recommendation to reschedule marijuana
    Episode transcripts
    For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions


    Embracing the mania and yield at a reasonable price Jan 29, 2024
    Show notes

    Rob Isbitts on the state of the ETF business (2:00) IBIT and recent spot Bitcoin ETF launch (6:15). Why Rob's looking at the dividend space right now (13:50) Pros and cons of owning dividend ETFs (24:45).
    Show Notes:
    XLI: Great Set Of Blue Chip Stocks, Sending Mixed Messages
    JD Henning Cautious About 2024, An Unusual Year For Market Considerations
    2024: The Year Of Living Dangerously
    My Top 3 YARP Stocks Right Now (Yield At A Reasonable Price)
    Seeking Alpha's Quant Performance
    Episode transcripts
    For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions


    Biotech and pharma diversification pays off Jan 25, 2024
    Show notes Alex Carchidi dissects the biotech sector - mostly highly risky, borderline investments. Diversification pays off (3:40). Funding is hard to come by and performance has not been great but ebb will give way to flow (6:00). Biotech and pharma; gene editing, gene therapy competitive story (7:45). Buy the rumor, sell the news is cliched but true for these stocks (17:00). Getting realistic about high price of drugs (20:05).
    Show Notes:
    CRISPR/Vertex gene editing therapy approved in U.S. for beta-thalassemia
    First RSV shots, groundbreaking gene therapy among 2024 drugs to watch
    Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets.
    Lilly, Novo Nordisk diabetes drugs see price raises - report
    Episode transcripts
    For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions

    JD Henning cautious about 2024, an unusual year for market considerations Jan 17, 2024
    Show notes

    JD Henning talks value, momentum, and combining fundamental with technical analysis (1:40). Investing vs trading portfolios (3:45). Cautious going into 2024; an unusual year for market considerations (7:50) If money flows are going out, it's a good time to concentrate on more positive sectors (13:15).
    Episode transcripts
    Show Notes:
    Webinar Replay: JD Henning's Momentum Breakout Models For 2024
    MDA Breakouts In Best Year Ever: New Picks For Week 1 - 2024
    Tracking Flows Of Smart Money With JD Henning
    Subscribe to JD's Value & Momentum Breakouts
    For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions


    Previous 1 23 24 25 26 27 39 Next

    Related Podcasts

    How I Built This with Guy Raz

    1

    How I Built This with Guy Raz Business
    Planet Money

    2

    Planet Money Business
    Inside Strategic Coach: Connecting Entrepreneurs With What Really Matters

    3

    Inside Strategic Coach: Connecting Entrepreneurs With What Really Matters Business
    BiggerPockets Real Estate Podcast

    4

    BiggerPockets Real Estate Podcast Business
    The Smart Passive Income Online Business and Blogging Podcast

    5

    The Smart Passive Income Online Business and Blogging Podcast Business
    Bad With Money With Gabe Dunn

    6

    Bad With Money With Gabe Dunn Business
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights